Welcome to Sequence Card of Peptide


Details of CancerPDF entry with Sequence TGKEKVTSGSTTTT
Primary information
sequence IDSeq_8193
Peptide sequenceTGKEKVTSGSTTTT
CancerPDF_ID CancerPDF_ID1235, CancerPDF_ID9671, CancerPDF_ID12417,
PMID21136997,21533267,26992070
Protein NameFibrinogen alpha,Fibrinogen alpha chain,Fibrinogen alpha chain
UniprotKB Entry NameFIBA_HUMAN,FIBA_HUMAN,FIBA_HUMAN
FluidSerum,Serum,Serum
M/Z1396.70455,699.35,1396.7046
Charge1,2,NA
Mass (in Da)NA,NA,1397.715885
fdrNA,NA,NA
Profiling TechniqueLC-MS,LC-MS,LC-MS
Peptide Identification techniqueLC-MS-MS/MS,LC/MS/MS,LC-MS/MS
Quantification TechniqueLC-ESI-MS,Multiple Reaction Monitoring,NA
Labelled/Label FreeLabel Free,Label Free,Label Free
FDRNA,1.49,FDR 1 %
CancerPDF_ID CancerPDF_ID1235, CancerPDF_ID9671, CancerPDF_ID12417,
p-ValueNA,NA,NA
SoftwareMASCOT(v. 2.2.01),MASCOT,SEQUEST and Maxquant
Length14,14,14
Cancer TypeColorectal cancer,Lung adenocarcinoma,Melanoma
DatabaseSwissProt Database,Swissprot Database (57.4),SwissProt Database
ModificationNA,NA,NA
Number of Patients30 patients and 30 healthy controls,62 lung adenocarcinoma and 30 healthy control,8 cancer samples and 4 healthy samples
RegulationNA,"Differentially expressed between earlier-stage lung cancer group (stage-I, II, and IIIa) vs normal","Present in 8 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples."
ValidationLeave One out Cross validation,MRM-based validation of 19 candidates,na
SensitivityNA,NA,NA
SpecificityNA,NA,NA
AccuracyNA,NA,NA
Peptide AtlasNA
IEDB